One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum
KeijiOzekiSatoshiTanidaHiromiKataoka
Recurrent Cholecystitis Due to Gallstone Obstruction of a Lumen-Apposing Metal Stent
SemGeertsemaRob J.MeindsNiels G.Venneman
Transient Uterine Prolapse: A Rare Complication of Endoscopic Polypectomy
KaiDeng12∗ZhihanWu12∗MoChen34
Bridging the Racial, Ethnic, and Gender Gap in Gastroenterology
ByronCryerSandraQuezadaJoan A.Culpepper-MorganLukejohnDayVivekKaulCelenaNuQuayM. BishrOmary
How to Promote Professional Identity Development and Support Fellows-In-Training Through Teaching, Coaching, Mentorship, and Sponsorship
IndiraBhavsar-BurkeChristen K.DillyAmy S.Oxentenko
Designing Your Ambulatory Endoscopy Center: Lessons from Accreditation
DeborahEdelman1NoelAdachi1Frank J.Chapman2Lawrence S.Kim3
Tegaserod: What’s Old Is New Again
Gregory S.Sayuk∗‡§JanTack||¶#
AGA Clinical Practice Update on Management of Short Bowel Syndrome: Expert Review
KishoreIyer1John K.DiBaise2AlbertoRubio-Tapia3
The COVID-19 Pandemic and Post-Infection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists
Walter W.Chan1MadhusudanGrover2
AGA White Paper: Challenges and Gaps in Innovation for the Performance of Colonoscopy for Screening and Surveillance of Colorectal Cancer
SrinadhKomanduri1Jason A.Dominitz2LindaRabeneck3CharlesKahi4UriLadabaum5Thomas F.Imperiale6Michael F.Byrne7Jeffrey K.Lee8DavidLieberman9Andrew Y.Wang10ShahnazSultan11AasmaShaukat12HeikoPohl1314V. RamanMuthusamy15
Nonalcoholic Fatty Liver Disease in Children: Where Are We?
JieLiMDRamseyCheungMD
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?
AndreaGiniPhDKevinSelbyMD, MAS
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States
Robert J.Huang∗MeiraEpplein‡ChisatoHamashima§Il JuChoi‖EunjungLee¶DennisDeapen¶YangheeWoo#ThuyTran#Shailja C.Shah∗∗‡‡John M.Inadomi§§David A.Greenwald‖‖Joo HaHwang∗
Duodenal Eosinophils and Mast Cells in Functional Dyspepsia: A Systematic Review and Meta-Analysis of Case-Control Studies
AyeshaShah∗‡§ThomasFairlie∗‡§GeorgiaBrown||Michael P.Jones¶Guy D.Eslick||KerithDuncanson||NikhilThapar∗#SimonKeely||NatashaKoloski∗‡||MohitShahi∗§Marjorie M.Walker||Nicholas J.Talley||GeraldHoltmann∗‡
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
Olga P.Nyssen∗DinoVaira‡Ã�ngelesPérez AÃsa§LuisRodrigo||ManuelCastro-Fernandez¶LaimasJonaitis#BojanTepes∗∗LiudmilaVologzhanina‡‡MarÃaCaldas∗AngelLanas§§Alfredo J.Lucendo||||LuisBujanda¶¶JuanOrtuño##JesúsBarrio∗∗∗Jose M.Huguet‡‡‡IrinaVoynovan§§§Jorge PerezLasala||||||Aiman SilkanovnaSarsenbaeva¶¶¶…AllaKononova
A Low FODMAP Diet Reduces Symptoms in Treated Celiac Patients With Ongoing Symptoms–A Randomized Controlled Trial
Fridavan Megen∗‡§Gry I.Skodje‡||SimonLergenmuller¶StephanieZühlke§LarsAabakken#Marit B.Veierød¶ChristineHenriksen‡§bKnut E.A.Lundin§#b
Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer
HaruyoshiTanaka∗aKojiTamura∗aToshiyaAbe∗aTakeichiYoshida∗AnneMacgregor-Das∗MohamadDbouk∗Amanda L.Blackford‡MichaelBorges§Anne MarieLennon§||JinHe§RichardBurkhart§Marcia IreneCanto‡||MichaelGoggins∗‡||
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease
OctaviBassegoda∗‡aPolOlivas∗‡§aLauraTurco‖MattiasMandorfer¶MiquelSerra-Burriel#LuisTellez‡∗∗WilhelmusKwanten‡‡AlexiaLaroyenne§§OanaFarcau‖‖EdilmarAlvaradoদLucileMoga##EliseVuille-Lessard∗∗∗Jose IgnacioFortea‡‡‡‡LuisIbañez‡§§§GiuliaTosetti‖‖‖ThomasVanwolleghem‡‡HélèneLarrue§§DiegoBurgos-SantamarÃa∗∗…VirginiaHernandez-Gea∗‡§
Pilot Randomized Controlled Trial of an Advance Care Planning Video Decision Tool for Patients With Advanced Liver Disease
Nneka N.Ufere∗BlairRobinson‡JohnDonlan§TeresaIndriolo∗JudithBloom∗AbigailScherrer∗Nancy M.Mason||ArpanPatel¶#Jennifer C.Lai∗∗Raymond T.Chung∗AngeloVolandes‡‡AreejEl-Jawahri§§
Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry
Zobair M.Younossi∗‡YusufYilmaz§||Ming-LungYu¶VincentWai-Sun Wong#Marlen CastellanosFernandez∗∗Vasily A.Isakov‡‡Ajay K.Duseja§§NahumMendez-Sanchez||||YuichiroEguchi¶¶ElisabettaBugianesi##PatriziaBurra∗∗∗JacobGeorge‡‡‡Jian-GaoFan§§§George V.Papatheodoridis||||||Wah KheongChan¶¶¶KhalidAlswat###Hamid S.Saeed∗∗∗∗Ashwani K.Singal‡‡‡‡…MariaStepanova§§§§§¶¶¶¶¶
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States
DongheeKim1OmarAlshuwaykh1Brittany B.Dennis2GeorgeCholankeril34AijazAhmed1
Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease
SanderLefere∗‡EllenDupont§AnnDe Guchtenaere||StephanieVan Biervliet¶SaskiaVande Velde¶XavierVerhelst∗LindseyDevisscher‡HansVan Vlierberghe∗AnjaGeerts∗bRuthDe Bruyne¶b
Test Characteristics of Cross-sectional Imaging and Concordance With Endoscopy in Postoperative Crohn’s Disease
Salam P.Bachour∗Ravi S.Shah‡RuishenLyu§TakahiroNakamura‖MichaelShen‖TerryLi‖BariDane¶Edward L.Barnes#FlorianRieder∗∗BenjaminCohen∗∗TahaQazi∗∗BretLashner∗∗Jean PaulAchkar∗∗JessicaPhilpott∗∗Stefan D.Holubar‡‡Amy L.Lightner‡‡MiguelRegueiro∗∗JordanAxelrad§§…BenjaminClick∗∗
Upadacitinib Was Efficacious and Well-tolerated Over 30 Months in Patients With Crohn’s Disease in the CELEST Extension Study
GeertD’Haens∗JulianPanés‡EdouardLouis§AnaLacerda||QianZhou¶JohnLiu#Edward V.LoftusJr.∗∗
Risk Factors for Incident Inflammatory Bowel Disease According to Disease Phenotype
Emily W.Lopes∗‡PaulLochhead∗Kristin E.Burke∗James M.Richter∗Ashwin N.Ananthakrishnan∗‡Andrew T.Chan∗‡§HamedKhalili∗‡||
Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study
BharatiKochar∗‡§∗∗JuuliaJylhävä||JonasSöderling¶Christine S.Ritchie§#∗∗ Jonas F.Ludvigsson||‡‡§§||||
Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor α Antagonists in Inflammatory Bowel Diseases
DavidCheng∗Bharati D.Kochar‡TianxiCai§Ashwin N.Ananthakrishnan‡
Effects of Attendance to an Organized Fecal Immunochemical Test Screening Program on the Risk of Colorectal Cancer: An Observational Cohort Study
FlaviaBaldacchini∗LauroBucchi∗OriettaGiuliani∗SilviaMancini∗AlessandraRavaioli∗RosaVattiato∗FedericaZamagni∗PaoloGiorgi Rossi‡LuciaMangone‡CinziaCampari§RomanoSassatelli||PaoloTrande¶PasqualinaEsposito#FedericaRossi#GiulianoCarrozzi∗∗OmeroTriossi‡‡aCarloFabbri§§EnricoStrocchi||||…DanieleTrombetti
Cost Effectiveness of Mailed Outreach Programs for Colorectal Cancer Screening: Analysis of a Pragmatic, Randomized Trial
Kandice A.Kapinos∗‡§Ethan A.Halm‖Caitlin C.Murphy∗¶Noel O.Santini#Adam C.Loewen∗Celette SuggSkinner∗‡aAmit G.Singal∗‡a
Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort
Miguel H.Malespin∗Alfred SidneyBarrittIV‡Stephanie E.Watkins§CherylSchoen§Monica A.Tincopa‖Karen D.Corbin¶Andrea R.Mospan§BredaMunoz§Huy N.Trinh#L. MichaelWeiss∗∗K. RajenderReddy‡‡RohitLoomba§§NyingiKemmer∗Anna S.Lok‖
FIB-4 Improves LSM-Based Prediction of Complications in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease
Yuly P.Mendoza∗‡MohamedShengir§JaimeBosch||¶GiadaSebastiani§#aAnnalisaBerzigotti∗¶a
Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis: A Multicenter Cohort Study
Rahul S.Dalal∗ScottEsckilsen‡Edward L.Barnes§Jordan C.Pruce∗JennaMarcus∗Jessica R.Allegretti∗
Histology, Size, and Number of Advanced Polyps are Associated With Guideline-Discordant Surveillance Recommendations
Jennifer M.Kolb∗Gregory L.Austin‡
Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis
Binu V.JohnMD, MPHA.Sidney BarrittIVMD, MSCRAndrewMoonMD, MPHTamar H.TaddeiMDDavid E.KaplanMDBassamDahmanPhDAkashDoshiBSYangyangDengMSNatalieMansourMDGeorgeIoannouMD, MSPaulMartinMDHann-HsiangChaoMD, PHD
Exam 1: Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
Exam 2: Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor α Antagonists in Inflammatory Bowel Diseases
Screening for Esophageal Adenocarcinoma: Should We Use Barrett’s Screening Protocols?
SuprabhatGiriMBBS, MD, DMSridharSundaramMBBS, MD, DM
Comment to “Chronic Constipation as a Risk Factor for Colorectal Cancer: Results From a Nationwide, Case-Control Study�
Yung-ShuoKaoMDJamesCheng-Chung WeiMD, PhD
Duodenal Barrier and Inflammation in Dyspepsia: God is in the Details
LucasWautersMD, PhDMatthiasCeulemansMScTimVanuytselMD, PhD
Reply
SusruthaPuthanmadhom NarayananMBBSMadhusudanGroverMBBSAdil E.BharuchaMBBS, MD
Digital Health Interventions for Colorectal Polyp Detection: Are We Ready for Prime Time?
TimothyPhanBBmed, MDAdamPetersonBPT, MBBS(Hons)SuongLeMBBS, MClinResMeth, MBA, PhD
Decompensation in Patients With Nonalcoholic Steatohepatitis: A Multihit Hypothesis
SrikantMohtaMD, DMaSanchitSharmaMD, DMaAnoopSarayaMD, DM, DNB
Reply
OctaviBassegodaMDPolOlivasMDIsabelGrauperaMD, PhDVirginiaHernández-GeaMD, PhD
No Association Between Nonalcoholic Fatty Liver Disease and Severe COVID-19? Something We Might Ignore
HuiGaoMSLeiXuMD
